Evidence map›Paper›PMID 24257210›Full record

ArticleRetrovirology2013

The S40 residue in HIV-1 Gag p6 impacts local and distal budding determinants, revealing additional late domain activities.

Susan M Watanabe, Min-Huei Chen, Mahfuz Khan, Lorna Ehrlich, Kimdar Sherefa Kemal, Barbara Weiser, Binshan Shi, Chaoping Chen, Michael Powell, Kathryn Anastos and 2 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Susan M WatanabeDepartment of Molecular Genetics & Microbiology, Stony Brook University, Life Sciences Bldg, Rm 248, Stony Brook, NY 11794-5222, USA. carol.carter@stonybrook.edu.
Min-Huei Chen
Mahfuz Khan
Lorna Ehrlich
Kimdar Sherefa Kemal
Barbara Weiser
Binshan Shi
Chaoping Chen
Michael Powell
Kathryn Anastos
Harold Burger
Carol A Carter
Stony Brook University · USMorehouse School of Medicine · USNew York State Department of Health · USWadsworth Center · USColorado State University · USMontefiore Medical Center · US

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
TRANSPLANTATION OF EXOSOMES FROM HYPOXIA-PRECONDITIONED ADIPOSE-DERIVED STEM CELLS PROMOTES ANGIOGENESIS IN ISCHEMIC HEARTG12MD007602 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI BOND, VINCENT C · 2012 to 2017
$18.4M
Cellular Protein Involved in Trafficking of HIV-1R01GM111028 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI CARTER, CAROL A · 2013 to 2019
$2.0M
Cellular Proteins Involved in Trafficking of HIV-1R01AI068463 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI CARTER, CAROL A · 2007 to 2010
$1.4M
Cellular Proteins Involved in Trafficking of HIV-1R56AI068463 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI CARTER, CAROL A · 2006 to 2012
$774k
Characterization of Nef vesicles and their effect on T cells and macrophageR21AI095150 · NIAID · MOREHOUSE SCHOOL OF MEDICINE · PI POWELL, MICHAEL D · 2011 to 2012
$389k
NIAID NIH HHS AI068463NIAID NIH HHS AI152015NIAID NIH HHS NIH R21 AI095150NIAID NIH HHS NIH U3U 01AI35004NIAID NIH HHS U01 AI035004NIGMS NIH HHS GM111028NIGMS NIH HHS R01 GM111028NIMHD NIH HHS 8G12MD007602PHS HHS NIH R21A1080351
6 · The paper itself

Abstract

backgroundHIV-1 budding is directed primarily by two motifs in Gag p6 designated as late domain-1 and -2 that recruit ESCRT machinery by binding Tsg101 and Alix, respectively, and by poorly characterized determinants in the capsid (CA) domain. Here, we report that a conserved Gag p6 residue, S40, impacts budding mediated by all of these determinants.

resultsWhereas budding normally results in formation of single spherical particles ~100 nm in diameter and containing a characteristic electron-dense conical core, the substitution of Phe for S40, a change that does not alter the amino acids encoded in the overlapping pol reading frame, resulted in defective CA-SP1 cleavage, formation of strings of tethered particles or filopodia-like membrane protrusions containing Gag, and diminished infectious particle formation. The S40F-mediated release defects were exacerbated when the viral-encoded protease (PR) was inactivated or when L domain-1 function was disrupted or when budding was almost completely obliterated by the disruption of both L domain-1 and -2. S40F mutation also resulted in stronger Gag-Alix interaction, as detected by yeast 2-hybrid assay. Reducing Alix binding by mutational disruption of contact residues restored single particle release, implicating the perturbed Gag-Alix interaction in the aberrant budding events. Interestingly, introduction of S40F partially rescued the negative effects on budding of CA NTD mutations EE75,76AA and P99A, which both prevent membrane curvature and therefore block budding at an early stage.

conclusionsThe results indicate that the S40 residue is a novel determinant of HIV-1 egress that is most likely involved in regulation of a critical assembly event required for budding in the Tsg101-, Alix-, Nedd4- and CA N-terminal domain affected pathways.

Indexed as

Host-Pathogen InteractionsVirus ReleaseAmino Acid SubstitutionAnimalsCalcium-Binding ProteinsCell Cycle ProteinsChlorocebus aethiopsCOS CellsDNA-Binding ProteinsEndosomal Sorting Complexes Required for Transportgag Gene Products, Human Immunodeficiency VirusHIV-1Microscopy, ElectronMutant ProteinsProtein BindingTranscription FactorsCalcium-Binding ProteinsCell Cycle ProteinsDNA-Binding ProteinsEndosomal Sorting Complexes Required for Transportgag Gene Products, Human Immunodeficiency VirusMutant Proteinsp6 gag protein, Human immunodeficiency virus 1PDCD6IP protein, humanTranscription FactorsTsg101 Protein

Identifiers

PMID24257210
PMCPMC3907034
OpenAlexW2168701196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.